Cancer Crosslinks will be presented on
Thursday, January 23, 2025
at Oslo Cancer Cluster Innovation Park
Bridging innovations to improve clinical outcomes for cancer patients.
Distinguished speakers from the UK, US, and the Nordics addressed emerging diagnostic and treatment options for solid and haematological cancers at Cancer Crosslinks 2025.
Daytime Educational Program: 09:30 Registration, 10:00 - 16:30 (CET), includes lunch.
Afternoon Networking Event: 16:30 onwards, includes tapas.
Location: Kaare Norum Auditorium, Ullernchausséen 64, Oslo, Norway (digital option).
Daytime Educational Program: 09:30 Registration, 10:00 - 16:30 (CET), includes lunch.
Afternoon Networking Event: 16:30 onwards, includes tapas.
Location: Kaare Norum Auditorium, Ullernchausséen 64, Oslo, Norway (digital option).
Program
09:30 - 10:00 Registration & Coffee
10:00 - 10:15 Opening
10:15 - 11:45 SESSION 1 - Advances in tumour-agnostic therapies for precision oncology
Speakers
Revolutionizing Cancer Therapy:
Breaking Barriers in Oncology with Tumor-Agnostic Drug Development
Vivek Subbiah, MD, Chief, Early-Phase Drug Development,
Sarah Cannon Research Institute (SCRI), Nashville, USA
Breaking Barriers in Oncology with Tumor-Agnostic Drug Development
Vivek Subbiah, MD, Chief, Early-Phase Drug Development,
Sarah Cannon Research Institute (SCRI), Nashville, USA
Can precision medicine deliver histology-independent drug discovery?
Ruth Plummer, Clinical Professor of Experimental Cancer Medicine,
Translational and Clinical Research Institute, Newcastle University Centre for Cancer,
Director of Sir Bobby Robson Cancer Trials Research Centre, Newcastle, UK
Ruth Plummer, Clinical Professor of Experimental Cancer Medicine,
Translational and Clinical Research Institute, Newcastle University Centre for Cancer,
Director of Sir Bobby Robson Cancer Trials Research Centre, Newcastle, UK
Moderators
Else Marit Inderberg, Unit leader, Translational Research Unit, Section for Cell Therapy,
Department of Oncology, Oslo University Hospital, Oslo, Norway
Department of Oncology, Oslo University Hospital, Oslo, Norway
Åsmund Flobak, Associate Professor at Norwegian University of Science and Technology (NTNU), Consultant oncologist at The Cancer Clinic, St. Olav's University Hospital,
Senior researcher at SINTEF, Trondheim, Norway
Senior researcher at SINTEF, Trondheim, Norway
11:45 - 12:45 An invitation to lunch
12:45 - 14:15 SESSION 2 - The potential of cell therapies in haematological malignancies and beyond
Speakers:
Arming CAR-T cells for potent bystander immune response in lymphoma and glioblastoma
Magnus Essand, Professor of Gene Therapy, Uppsala University, Department of Immunology,
Genetics and Pathology, Uppsala, Sweden
Magnus Essand, Professor of Gene Therapy, Uppsala University, Department of Immunology,
Genetics and Pathology, Uppsala, Sweden
Prime time for adoptive T-cell therapy for metastatic melanoma
Inge Marie Svane, Professor, MD, Director, National Center for Cancer Immune Therapy – CCIT-DK, Department of Oncology, Herlev Hospital, Copenhagen University, Denmark
Inge Marie Svane, Professor, MD, Director, National Center for Cancer Immune Therapy – CCIT-DK, Department of Oncology, Herlev Hospital, Copenhagen University, Denmark
Moderators:
Else Marit Inderberg, Unit leader, Translational Research Unit, Section for Cell Therapy,
Department of Oncology, Oslo University Hospital, Oslo, Norway
Department of Oncology, Oslo University Hospital, Oslo, Norway
Åsmund Flobak, Associate Professor at Norwegian University of Science and Technology (NTNU), Consultant oncologist at The Cancer Clinic, St. Olav's University Hospital,
Senior researcher at SINTEF, Trondheim, Norway
Senior researcher at SINTEF, Trondheim, Norway
14:15 - 14:45 COFFEE BREAK
14:45 - 15:45 SESSION 3 - Pioneering digital innovations in clinical practice
Speakers:
From diagnosis to recovery, how digital innovations are transforming the cancer patient journey
Ingrid Stenstadvold Ross, Secretary General, Norwegian Cancer Society
Ingrid Stenstadvold Ross, Secretary General, Norwegian Cancer Society
AIDA - A national collaboration arena for clinical innovation in medical imaging diagnostics AI
Joel Hedlund, PhD, Data Director Center for Medical Image Science and Visualization (CMIV)/Analytic Imaging Diagnostics Arena (AIDA), AIDA Data Hub Lead, Linköping University, Sweden
Joel Hedlund, PhD, Data Director Center for Medical Image Science and Visualization (CMIV)/Analytic Imaging Diagnostics Arena (AIDA), AIDA Data Hub Lead, Linköping University, Sweden
Moderators:
Eli Sihn Samdal Steinskog, MD, PhD, Chief Physician and Senior Consultant in Oncology,
Molde Hospital, Norway. Study Doctor IMPRESS-Norway, Department of Oncology,
Haukeland University Hospital, Bergen, Norway
Molde Hospital, Norway. Study Doctor IMPRESS-Norway, Department of Oncology,
Haukeland University Hospital, Bergen, Norway
Hanne Mari Hamre, MD PhD, Consultant Oncologist, Akershus University Hospital, Norway
15:45 - 16:15 Panel Discussion with all speakers
16:15 - 16:30 Closing Remarks
Afternoon Networking
16:30 - 19:00 A welcome to all attendees for tapas and a Norwegian sparkling juices bar.
Event 2025 - Travel Voucher
A limited number of travel vouchers are available for clinicians and healthcare personnel based in Norway (domestic travel). Please contact Charlotte Homme [email protected] for more information.
A limited number of travel vouchers are available for clinicians and healthcare personnel based in Norway (domestic travel). Please contact Charlotte Homme [email protected] for more information.
|
Organizer
|
Sponsors 2025
|
|
|
|
To learn more about previous Cancer Crosslinks events, visit the GALLERY.